{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:32:53Z","timestamp":1789425173437,"version":"build-2803163510"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s11064-025-04505-9","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T07:52:32Z","timestamp":1753775552000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Intranasal Terpene Treatment for Glioblastoma: the Neuro-Oncological Potential of Perillyl Alcohol"],"prefix":"10.1007","volume":"50","author":[{"given":"Emirhan","family":"Harbi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhan","family":"Yarar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher E.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Aschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aytug","family":"Altundag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"key":"4505_CR1","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro Oncol"},{"key":"4505_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant Temozolomide for glioblastoma. N Engl J Med 352:987\u2013996. https:\/\/doi.org\/10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"key":"4505_CR3","doi-asserted-by":"publisher","unstructured":"Khagi S, Kotecha R, Gatson NTN et al (2025) Recent advances in tumor treating fields (TTFields) therapy for glioblastoma. Oncologist 30. https:\/\/doi.org\/10.1093\/oncolo\/oyae227","DOI":"10.1093\/oncolo\/oyae227"},{"key":"4505_CR4","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1586\/14737175.2015.1051968","volume":"15","author":"B Auffinger","year":"2015","unstructured":"Auffinger B, Spencer D, Pytel P et al (2015) The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence. Expert Rev Neurother 15:741\u2013752. https:\/\/doi.org\/10.1586\/14737175.2015.1051968","journal-title":"Expert Rev Neurother"},{"key":"4505_CR5","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3390\/cells10030484","volume":"10","author":"A Goenka","year":"2021","unstructured":"Goenka A, Tiek D, Song X et al (2021) The many facets of therapy resistance and tumor recurrence in glioblastoma. Cells 10:484. https:\/\/doi.org\/10.3390\/cells10030484","journal-title":"Cells"},{"key":"4505_CR6","doi-asserted-by":"publisher","first-page":"12654","DOI":"10.3390\/ijms222312654","volume":"22","author":"F Mo","year":"2021","unstructured":"Mo F, Pellerino A, Soffietti R, Rud\u00e0 R (2021) Blood\u2013Brain barrier in brain tumors: biology and clinical relevance. Int J Mol Sci 22:12654. https:\/\/doi.org\/10.3390\/ijms222312654","journal-title":"Int J Mol Sci"},{"key":"4505_CR7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu D, Chen Q, Chen X et al (2023) The blood\u2013brain barrier: structure, regulation and drug delivery. Signal Transduct Target Ther 8:217. https:\/\/doi.org\/10.1038\/s41392-023-01481-w","journal-title":"Signal Transduct Target Ther"},{"key":"4505_CR8","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.3390\/ijms23084153","volume":"23","author":"AM Hersh","year":"2022","unstructured":"Hersh AM, Alomari S, Tyler BM (2022) Crossing the Blood-Brain barrier: advances in nanoparticle technology for drug delivery in Neuro-Oncology. Int J Mol Sci 23:4153. https:\/\/doi.org\/10.3390\/ijms23084153","journal-title":"Int J Mol Sci"},{"key":"4505_CR9","doi-asserted-by":"publisher","unstructured":"Giantini-Larsen AM, Pandey A, Garton ALA et al (2025) Therapeutic manipulation and bypass of the blood\u2013brain barrier: powerful tools in glioma treatment. Neurooncol Adv 7. https:\/\/doi.org\/10.1093\/noajnl\/vdae201","DOI":"10.1093\/noajnl\/vdae201"},{"key":"4505_CR10","doi-asserted-by":"crossref","unstructured":"Trevino JT, Quispe RC, Khan F, Novak V (2020) Non-Invasive strategies for Nose-to-Brain drug delivery. J Clin Trials 10","DOI":"10.46354\/i3m.2019.iwish.017"},{"key":"4505_CR11","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1186\/1471-2202-9-S3-S5","volume":"9","author":"LR Hanson","year":"2008","unstructured":"Hanson LR, Frey WH (2008) Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC Neurosci 9:S5. https:\/\/doi.org\/10.1186\/1471-2202-9-S3-S5","journal-title":"BMC Neurosci"},{"key":"4505_CR12","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.jconrel.2024.12.058","volume":"378","author":"J Koo","year":"2025","unstructured":"Koo J, Shin Y, Jeon H et al (2025) Enhancing glioblastoma therapy via intranasal administration of highly potent cell-penetrating peptide decorated nanoparticles. J Controlled Release 378:997\u20131012. https:\/\/doi.org\/10.1016\/j.jconrel.2024.12.058","journal-title":"J Controlled Release"},{"key":"4505_CR13","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1021\/acs.molpharmaceut.4c00703","volume":"22","author":"TG Agnihotri","year":"2025","unstructured":"Agnihotri TG, Dahifale A, Gomte SS et al (2025) Nanosystems at nexus: navigating Nose-to-Brain delivery for glioblastoma treatment. Mol Pharm 22:599\u2013619. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.4c00703","journal-title":"Mol Pharm"},{"key":"4505_CR14","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.2147\/IJN.S439181","volume":"19","author":"J Koo","year":"2024","unstructured":"Koo J, Lim C, Oh KT (2024) Recent advances in intranasal administration for Brain-Targeting delivery: A comprehensive review of Lipid-Based nanoparticles and Stimuli-Responsive gel formulations. Int J Nanomed Volume 19:1767\u20131807. https:\/\/doi.org\/10.2147\/IJN.S439181","journal-title":"Int J Nanomed Volume"},{"key":"4505_CR15","doi-asserted-by":"publisher","first-page":"112905","DOI":"10.1016\/j.ejmech.2020.112905","volume":"209","author":"S Mignani","year":"2021","unstructured":"Mignani S, Shi X, Karpus A, Majoral J-P (2021) Non-invasive intranasal administration route directly to the brain using dendrimer nanoplatforms: an opportunity to develop new CNS drugs. Eur J Med Chem 209:112905. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112905","journal-title":"Eur J Med Chem"},{"key":"4505_CR16","doi-asserted-by":"publisher","unstructured":"Altundag A, Harbi E, Cayonu M (2025) Terpene-centered olfactory training in postinfectious olfactory dysfunction: a dual-route approach. Laryngoscope. https:\/\/doi.org\/10.1002\/lary.32432","DOI":"10.1002\/lary.32432"},{"key":"4505_CR17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.lfs.2017.12.025","volume":"195","author":"TP Crowe","year":"2018","unstructured":"Crowe TP, Greenlee MHW, Kanthasamy AG, Hsu WH (2018) Mechanism of intranasal drug delivery directly to the brain. Life Sci 195:44\u201352. https:\/\/doi.org\/10.1016\/j.lfs.2017.12.025","journal-title":"Life Sci"},{"key":"4505_CR18","doi-asserted-by":"publisher","unstructured":"Huang Q, Chen X, Yu S et al (2024) Research progress in brain-targeted nasal drug delivery. Front Aging Neurosci 15. https:\/\/doi.org\/10.3389\/fnagi.2023.1341295","DOI":"10.3389\/fnagi.2023.1341295"},{"key":"4505_CR19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/pharmaceutics11030129","volume":"11","author":"B Homayun","year":"2019","unstructured":"Homayun B, Lin X, Choi H-J (2019) Challenges and recent progress in oral drug delivery systems for biopharmaceuticals. Pharmaceutics 11:129. https:\/\/doi.org\/10.3390\/pharmaceutics11030129","journal-title":"Pharmaceutics"},{"key":"4505_CR20","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1080\/10837450902891295","volume":"41","author":"MS Benedetti","year":"2009","unstructured":"Benedetti MS, Whomsley R, Poggesi I et al (2009) Drug metabolism and pharmacokinetics. Drug Metab Rev 41:344\u2013390. https:\/\/doi.org\/10.1080\/10837450902891295","journal-title":"Drug Metab Rev"},{"key":"4505_CR21","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/j.1552-4604.1993.tb04720.x","volume":"33","author":"D Lalka","year":"1993","unstructured":"Lalka D, Griffith RK, Cronenberger CL (1993) The hepatic First-Pass metabolism of problematic drugs. J Clin Pharmacol 33:657\u2013669. https:\/\/doi.org\/10.1002\/j.1552-4604.1993.tb04720.x","journal-title":"J Clin Pharmacol"},{"key":"4505_CR22","doi-asserted-by":"publisher","first-page":"101896","DOI":"10.1016\/j.ctrv.2019.101896","volume":"80","author":"E Le Rhun","year":"2019","unstructured":"Le Rhun E, Preusser M, Roth P et al (2019) Molecular targeted therapy of glioblastoma. Cancer Treat Rev 80:101896. https:\/\/doi.org\/10.1016\/j.ctrv.2019.101896","journal-title":"Cancer Treat Rev"},{"key":"4505_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ol.2025.14989","volume":"29","author":"M Al Ghafari","year":"2025","unstructured":"Al Ghafari M, El Jaafari N, Mouallem M et al (2025) Key genes altered in glioblastoma based on bioinformatics (Review). Oncol Lett 29:1\u201316. https:\/\/doi.org\/10.3892\/ol.2025.14989","journal-title":"Oncol Lett"},{"key":"4505_CR24","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00401-018-1905-0","volume":"136","author":"D Stichel","year":"2018","unstructured":"Stichel D, Ebrahimi A, Reuss D et al (2018) Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt Astrocytoma to glioblastoma. Acta Neuropathol 136:793\u2013803. https:\/\/doi.org\/10.1007\/s00401-018-1905-0","journal-title":"Acta Neuropathol"},{"key":"4505_CR25","doi-asserted-by":"publisher","unstructured":"Liu EM, Shi Z, Li KK et al (2022) Molecular landscape of <\u2009scp\u2009>IDH -wild type, <scp\u2009>\u2009p TERT \u2010wild type adult glioblastomas<\/scp\u2009>. Brain Pathol 32. https:\/\/doi.org\/10.1111\/bpa.13107","DOI":"10.1111\/bpa.13107"},{"key":"4505_CR26","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.32604\/or.2024.052130","volume":"32","author":"DP VAGELI","year":"2024","unstructured":"Vageli DP, Doukas PG, Goupou K et al (2024) Hypoxia-inducible factor 1alpha and vascular endothelial growth factor in glioblastoma multiforme: a systematic review going beyond pathologic implications. Oncol Res 32:1239\u20131256. https:\/\/doi.org\/10.32604\/or.2024.052130","journal-title":"Oncol Res"},{"key":"4505_CR27","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1750-3639.2005.tb00115.x","volume":"15","author":"I Fischer","year":"2005","unstructured":"Fischer I, Gagner J, Law M et al (2005) Angiogenesis in gliomas: biology and molecular pathophysiology. Brain Pathol 15:297\u2013310. https:\/\/doi.org\/10.1111\/j.1750-3639.2005.tb00115.x","journal-title":"Brain Pathol"},{"key":"4505_CR28","doi-asserted-by":"publisher","unstructured":"Harbi E, Aschner M (2024) Nuclear medicine imaging techniques in glioblastomas. Neurochem Res 49(11):3006\u20133013. https:\/\/doi.org\/10.1007\/s11064-024-04233-6","DOI":"10.1007\/s11064-024-04233-6"},{"key":"4505_CR29","doi-asserted-by":"publisher","unstructured":"Jung (2010) Changes of the O6-methylguanine-DNA methyltransferase promoter methylation and MGMT protein expression after adjuvant treatment in glioblastoma. Oncol Rep 23. https:\/\/doi.org\/10.3892\/or_00000760","DOI":"10.3892\/or_00000760"},{"key":"4505_CR30","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.3390\/cancers11121837","volume":"11","author":"J Feldheim","year":"2019","unstructured":"Feldheim J, Kessler AF, Monoranu CM et al (2019) Changes of O6-Methylguanine DNA methyltransferase (MGMT) promoter methylation in glioblastoma Relapse\u2014A Meta-Analysis type literature review. Cancers (Basel) 11:1837. https:\/\/doi.org\/10.3390\/cancers11121837","journal-title":"Cancers (Basel)"},{"key":"4505_CR31","doi-asserted-by":"publisher","unstructured":"Yu W, Zhang L, Wei Q, Shao A (2020) O6-Methylguanine-DNA methyltransferase (MGMT): challenges and new opportunities in glioma chemotherapy. Front Oncol 9. https:\/\/doi.org\/10.3389\/fonc.2019.01547","DOI":"10.3389\/fonc.2019.01547"},{"key":"4505_CR32","doi-asserted-by":"publisher","first-page":"119673","DOI":"10.1016\/j.bbamcr.2024.119673","volume":"1871","author":"R Shaw","year":"2024","unstructured":"Shaw R, Basu M, Karmakar S, Ghosh MK (2024) MGMT in TMZ-based glioma therapy: multifaceted insights and clinical trial perspectives. Biochimica et biophysica acta (BBA) -. Mol Cell Res 1871:119673. https:\/\/doi.org\/10.1016\/j.bbamcr.2024.119673","journal-title":"Mol Cell Res"},{"key":"4505_CR33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s40005-022-00589-5","volume":"53","author":"S-H Jeong","year":"2023","unstructured":"Jeong S-H, Jang J-H, Lee Y-B (2023) Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors. J Pharm Investig 53:119\u2013152. https:\/\/doi.org\/10.1007\/s40005-022-00589-5","journal-title":"J Pharm Investig"},{"key":"4505_CR34","doi-asserted-by":"publisher","first-page":"101631","DOI":"10.1016\/j.apmt.2022.101631","volume":"29","author":"ML Formica","year":"2022","unstructured":"Formica ML, Real DA, Picchio ML et al (2022) On a highway to the brain: A review on nose-to-brain drug delivery using nanoparticles. Appl Mater Today 29:101631. https:\/\/doi.org\/10.1016\/j.apmt.2022.101631","journal-title":"Appl Mater Today"},{"key":"4505_CR35","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3390\/pharmaceutics14051073","volume":"14","author":"J Tai","year":"2022","unstructured":"Tai J, Han M, Lee D et al (2022) Different methods and formulations of drugs and vaccines for nasal administration. Pharmaceutics 14:1073. https:\/\/doi.org\/10.3390\/pharmaceutics14051073","journal-title":"Pharmaceutics"},{"key":"4505_CR36","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.3390\/ijms24043390","volume":"24","author":"E Marcello","year":"2023","unstructured":"Marcello E, Chiono V (2023) Biomaterials-Enhanced intranasal delivery of drugs as a direct route for brain targeting. Int J Mol Sci 24:3390. https:\/\/doi.org\/10.3390\/ijms24043390","journal-title":"Int J Mol Sci"},{"key":"4505_CR37","doi-asserted-by":"crossref","unstructured":"Fernandes C, Costa A, Os\u00f3rio L et al (2017) Current Standards of Care in Glioblastoma Therapy. In: Glioblastoma. Codon Publications, pp 197\u2013241","DOI":"10.15586\/codon.glioblastoma.2017.ch11"},{"key":"4505_CR38","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-024-02107-5","volume":"10","author":"W Xiao","year":"2025","unstructured":"Xiao W, Jiang W, Chen Z et al (2025) Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines. Signal Transduct Target Ther 10:74. https:\/\/doi.org\/10.1038\/s41392-024-02107-5","journal-title":"Signal Transduct Target Ther"},{"key":"4505_CR39","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.3390\/cells12121643","volume":"12","author":"LB De Martini","year":"2023","unstructured":"De Martini LB, Sulmona C, Brambilla L, Rossi D (2023) Cell-Penetrating peptides as valuable tools for Nose-to-Brain delivery of biological drugs. Cells 12:1643. https:\/\/doi.org\/10.3390\/cells12121643","journal-title":"Cells"},{"key":"4505_CR40","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.3390\/pharmaceutics15112599","volume":"15","author":"SK Niazi","year":"2023","unstructured":"Niazi SK (2023) Non-Invasive drug delivery across the Blood\u2013Brain barrier: A prospective analysis. Pharmaceutics 15:2599. https:\/\/doi.org\/10.3390\/pharmaceutics15112599","journal-title":"Pharmaceutics"},{"key":"4505_CR41","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.3390\/ijms19123905","volume":"19","author":"TC Chen","year":"2018","unstructured":"Chen TC, Da Fonseca CO, Sch\u00f6nthal AH (2018) Intranasal Perillyl alcohol for glioma therapy: molecular mechanisms and clinical development. Int J Mol Sci 19:3905. https:\/\/doi.org\/10.3390\/ijms19123905","journal-title":"Int J Mol Sci"},{"key":"4505_CR42","doi-asserted-by":"crossref","unstructured":"Dom\u00ednguez-Mart\u00edn EM, Magalh\u00e3es M, Efferth T et al (2023) Terpenes: A hope for glioblastoma patients. New insights into glioblastoma. Elsevier, pp 227\u2013269","DOI":"10.1016\/B978-0-323-99873-4.00014-1"},{"key":"4505_CR43","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3390\/nano14010055","volume":"14","author":"TN Pashirova","year":"2023","unstructured":"Pashirova TN, Nemtarev AV, Buzyurova DN et al (2023) Terpenes-Modified lipid nanosystems for temozolomide, improving cytotoxicity against glioblastoma human Cancer cells in vitro. Nanomaterials 14:55. https:\/\/doi.org\/10.3390\/nano14010055","journal-title":"Nanomaterials"},{"key":"4505_CR44","doi-asserted-by":"publisher","first-page":"100549","DOI":"10.1016\/j.phyplu.2024.100549","volume":"4","author":"T Siddiqui","year":"2024","unstructured":"Siddiqui T, Khan MU, Sharma V, Gupta K (2024) Terpenoids in essential oils: chemistry, classification, and potential impact on human health and industry. Phytomedicine Plus 4:100549. https:\/\/doi.org\/10.1016\/j.phyplu.2024.100549","journal-title":"Phytomedicine Plus"},{"key":"4505_CR45","doi-asserted-by":"publisher","first-page":"6044","DOI":"10.3390\/molecules29246044","volume":"29","author":"M Russo","year":"2024","unstructured":"Russo M, Martella N, Gargano D et al (2024) Lavender essential oil and its terpenic components negatively affect tumor properties in a cell model of glioblastoma. Molecules 29:6044. https:\/\/doi.org\/10.3390\/molecules29246044","journal-title":"Molecules"},{"key":"4505_CR46","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.colsurfb.2010.08.018","volume":"82","author":"C-H Liu","year":"2011","unstructured":"Liu C-H, Chang F-Y, Hung D-K (2011) Terpene microemulsions for transdermal Curcumin delivery: effects of terpenes and cosurfactants. Colloids Surf B Biointerfaces 82:63\u201370. https:\/\/doi.org\/10.1016\/j.colsurfb.2010.08.018","journal-title":"Colloids Surf B Biointerfaces"},{"key":"4505_CR47","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/pharmaceutics11020084","volume":"11","author":"MC Bonferoni","year":"2019","unstructured":"Bonferoni MC, Rossi S, Sandri G et al (2019) Nanoemulsions for Nose-to-Brain. Drug Delivery Pharm 11:84. https:\/\/doi.org\/10.3390\/pharmaceutics11020084","journal-title":"Drug Delivery Pharm"},{"key":"4505_CR48","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.3390\/molecules21121709","volume":"21","author":"J Chen","year":"2016","unstructured":"Chen J, Jiang Q-D, Chai Y-P et al (2016) Natural terpenes as penetration enhancers for transdermal drug delivery. Molecules 21:1709. https:\/\/doi.org\/10.3390\/molecules21121709","journal-title":"Molecules"},{"key":"4505_CR49","doi-asserted-by":"publisher","first-page":"738","DOI":"10.3390\/biom9110738","volume":"9","author":"B Salehi","year":"2019","unstructured":"Salehi B, Upadhyay S, Erdogan Orhan I et al (2019) Therapeutic potential of \u03b1- and \u03b2-Pinene: A miracle gift of nature. Biomolecules 9:738. https:\/\/doi.org\/10.3390\/biom9110738","journal-title":"Biomolecules"},{"key":"4505_CR50","doi-asserted-by":"publisher","first-page":"100217","DOI":"10.1016\/j.fochx.2022.100217","volume":"13","author":"A Masyita","year":"2022","unstructured":"Masyita A, Mustika Sari R, Dwi Astuti A et al (2022) Terpenes and terpenoids as main bioactive compounds of essential oils, their roles in human health and potential application as natural food preservatives. Food Chem X 13:100217. https:\/\/doi.org\/10.1016\/j.fochx.2022.100217","journal-title":"Food Chem X"},{"key":"4505_CR51","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.3390\/cancers14051100","volume":"14","author":"S Kamran","year":"2022","unstructured":"Kamran S, Sinniah A, Abdulghani MAM, Alshawsh MA (2022) Therapeutic potential of certain terpenoids as anticancer agents: A scoping review. Cancers (Basel) 14:1100. https:\/\/doi.org\/10.3390\/cancers14051100","journal-title":"Cancers (Basel)"},{"key":"4505_CR52","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1111\/1750-3841.14143","volume":"83","author":"X Meng","year":"2018","unstructured":"Meng X, Dong X, Wang W et al (2018) Natural Borneol enhances Paclitaxel-Induced apoptosis of ESCC cells by inactivation of the PI3K\/AKT. J Food Sci 83:1436\u20131443. https:\/\/doi.org\/10.1111\/1750-3841.14143","journal-title":"J Food Sci"},{"key":"4505_CR53","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3390\/ijms19051370","volume":"19","author":"T-Y Yang","year":"2018","unstructured":"Yang T-Y, Wu Y-J, Chang C-I et al (2018) The effect of Bornyl cis-4-Hydroxycinnamate on melanoma cell apoptosis is associated with mitochondrial dysfunction and Endoplasmic reticulum stress. Int J Mol Sci 19:1370. https:\/\/doi.org\/10.3390\/ijms19051370","journal-title":"Int J Mol Sci"},{"key":"4505_CR54","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s00432-023-05572-7","volume":"150","author":"A Shi","year":"2024","unstructured":"Shi A, Liu L, Li S, Qi B (2024) Natural products targeting the MAPK-signaling pathway in cancer: overview. J Cancer Res Clin Oncol 150:6. https:\/\/doi.org\/10.1007\/s00432-023-05572-7","journal-title":"J Cancer Res Clin Oncol"},{"key":"4505_CR55","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1002\/ptr.6170","volume":"32","author":"JI Erices","year":"2018","unstructured":"Erices JI, Torres \u00c1, Niechi I et al (2018) Current natural therapies in the treatment against glioblastoma. Phytother Res 32:2191\u20132201. https:\/\/doi.org\/10.1002\/ptr.6170","journal-title":"Phytother Res"},{"key":"4505_CR56","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.3390\/cancers13112765","volume":"13","author":"T Behl","year":"2021","unstructured":"Behl T, Sharma A, Sharma L et al (2021) Current perspective on the natural compounds and drug delivery techniques in glioblastoma multiforme. Cancers (Basel) 13:2765. https:\/\/doi.org\/10.3390\/cancers13112765","journal-title":"Cancers (Basel)"},{"key":"4505_CR57","doi-asserted-by":"publisher","first-page":"5511","DOI":"10.1039\/D4NA00678J","volume":"6","author":"OAA Alabrahim","year":"2024","unstructured":"Alabrahim OAA, Lababidi JM, Fritzsche W, Azzazy HME-S (2024) Beyond aromatherapy: can essential oil loaded nanocarriers revolutionize cancer treatment? Nanoscale Adv 6:5511\u20135562. https:\/\/doi.org\/10.1039\/D4NA00678J","journal-title":"Nanoscale Adv"},{"key":"4505_CR58","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3892\/ijo.2023.5567","volume":"63","author":"Y Tian","year":"2023","unstructured":"Tian Y, Lei Y, Wang Y et al (2023) Mechanism of multidrug resistance to chemotherapy mediated by Pglycoprotein (Review). Int J Oncol 63:119. https:\/\/doi.org\/10.3892\/ijo.2023.5567","journal-title":"Int J Oncol"},{"key":"4505_CR59","doi-asserted-by":"publisher","first-page":"100054","DOI":"10.1016\/j.crphar.2021.100054","volume":"2","author":"P Famta","year":"2021","unstructured":"Famta P, Shah S, Chatterjee E et al (2021) Exploring new horizons in overcoming P-glycoprotein-mediated multidrug-resistant breast cancer via nanoscale drug delivery platforms. Curr Res Pharmacol Drug Discovery 2:100054. https:\/\/doi.org\/10.1016\/j.crphar.2021.100054","journal-title":"Curr Res Pharmacol Drug Discovery"},{"key":"4505_CR60","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/scipharm87030017","volume":"87","author":"DS Shaker","year":"2019","unstructured":"Shaker DS, Ishak RAH, Ghoneim A, Elhuoni MA (2019) Nanoemulsion: A review on mechanisms for the transdermal delivery of hydrophobic and hydrophilic drugs. Sci Pharm 87:17. https:\/\/doi.org\/10.3390\/scipharm87030017","journal-title":"Sci Pharm"},{"key":"4505_CR61","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3390\/pharmaceutics17030337","volume":"17","author":"MD Chatzidaki","year":"2025","unstructured":"Chatzidaki MD, Mitsou E (2025) Advancements in Nanoemulsion-Based drug delivery across different administration routes. Pharmaceutics 17:337. https:\/\/doi.org\/10.3390\/pharmaceutics17030337","journal-title":"Pharmaceutics"},{"key":"4505_CR62","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.3390\/pharmaceutics16101333","volume":"16","author":"S Jacob","year":"2024","unstructured":"Jacob S, Kather FS, Boddu SHS et al (2024) Innovations in nanoemulsion technology: enhancing drug delivery for oral, parenteral, and ophthalmic applications. Pharmaceutics 16:1333. https:\/\/doi.org\/10.3390\/pharmaceutics16101333","journal-title":"Pharmaceutics"},{"key":"4505_CR63","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.2174\/0113816128293758240318080527","volume":"30","author":"WS Alharbi","year":"2024","unstructured":"Alharbi WS, Alshehri AA, Ahmed TA et al (2024) Enhancing the antiproliferative activity of Perillyl alcohol against glioblastoma cell lines through synergistic formulation with natural oils. Curr Pharm Des 30:1075\u20131084. https:\/\/doi.org\/10.2174\/0113816128293758240318080527","journal-title":"Curr Pharm Des"},{"key":"4505_CR64","doi-asserted-by":"crossref","unstructured":"Shojaei S, Kiumarsi A, Moghadam AR et al (2014) Perillyl Alcohol (Monoterpene Alcohol), Limonene. pp 7\u201332","DOI":"10.1016\/B978-0-12-802215-3.00002-1"},{"key":"4505_CR65","doi-asserted-by":"publisher","first-page":"6351","DOI":"10.1038\/s41598-021-85293-4","volume":"11","author":"G Nehra","year":"2021","unstructured":"Nehra G, Andrews S, Rettig J et al (2021) Intranasal administration of the chemotherapeutic Perillyl alcohol results in selective delivery to the cerebrospinal fluid in rats. Sci Rep 11:6351. https:\/\/doi.org\/10.1038\/s41598-021-85293-4","journal-title":"Sci Rep"},{"key":"4505_CR66","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0378-4347(99)00065-1","volume":"728","author":"Z Zhang","year":"1999","unstructured":"Zhang Z, Chen H, Chan KK et al (1999) Gas chromatographic\u2013mass spectrometric analysis of Perillyl alcohol and metabolites in plasma. J Chromatogr B Biomed Sci Appl 728:85\u201395. https:\/\/doi.org\/10.1016\/S0378-4347(99)00065-1","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"4505_CR67","doi-asserted-by":"publisher","first-page":"100090","DOI":"10.1016\/j.phyplu.2021.100090","volume":"1","author":"AO Dur\u00e7o","year":"2021","unstructured":"Dur\u00e7o AO, Concei\u00e7\u00e3o LSR, de Souza DS et al (2021) Perillyl alcohol as a treatment for cancer: A systematic review. Phytomedicine Plus 1:100090. https:\/\/doi.org\/10.1016\/j.phyplu.2021.100090","journal-title":"Phytomedicine Plus"},{"key":"4505_CR68","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00005-008-0027-0","volume":"56","author":"CO da Fonseca","year":"2008","unstructured":"da Fonseca CO, Linden R, Futuro D et al (2008) Ras pathway activation in gliomas: a strategic target for intranasal administration of Perillyl alcohol. Arch Immunol Ther Exp (Warsz) 56:267\u2013276. https:\/\/doi.org\/10.1007\/s00005-008-0027-0","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"4505_CR69","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/BF00685549","volume":"31","author":"PL Crowell","year":"1992","unstructured":"Crowell PL, Lin S, Vedejs E, Gould MN (1992) Identification of metabolites of the antitumor agentd-limonene capable of inhibiting protein isoprenylation and cell growth. Cancer Chemother Pharmacol 31:205\u2013212. https:\/\/doi.org\/10.1007\/BF00685549","journal-title":"Cancer Chemother Pharmacol"},{"key":"4505_CR70","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/0006-2952(94)90341-7","volume":"47","author":"PL Crowell","year":"1994","unstructured":"Crowell PL, Ren Z, Lin S et al (1994) Structure-activity relationships among monoterpene inhibitors of protein isoprenylation and cell proliferation. Biochem Pharmacol 47:1405\u20131415. https:\/\/doi.org\/10.1016\/0006-2952(94)90341-7","journal-title":"Biochem Pharmacol"},{"key":"4505_CR71","doi-asserted-by":"publisher","first-page":"35968","DOI":"10.1074\/jbc.M303280200","volume":"278","author":"D Rajesh","year":"2003","unstructured":"Rajesh D, Stenzel RA, Howard SP (2003) Perillyl alcohol as a Radio-\/Chemosensitizer in malignant glioma. J Biol Chem 278:35968\u201335978. https:\/\/doi.org\/10.1074\/jbc.M303280200","journal-title":"J Biol Chem"},{"key":"4505_CR72","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1158\/1535-7163.MCT-13-0964","volume":"13","author":"H-Y Cho","year":"2014","unstructured":"Cho H-Y, Wang W, Jhaveri N et al (2014) NEO212, Temozolomide conjugated to Perillyl alcohol, is a novel drug for effective treatment of a broad range of Temozolomide-Resistant gliomas. Mol Cancer Ther 13:2004\u20132017. https:\/\/doi.org\/10.1158\/1535-7163.MCT-13-0964","journal-title":"Mol Cancer Ther"},{"key":"4505_CR73","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1215\/15228517-2008-006","volume":"10","author":"HK Lee","year":"2008","unstructured":"Lee HK, Xiang C, Cazacu S et al (2008) GRP78 is overexpressed in glioblastomas and regulates glioma cell growth and apoptosis. Neuro Oncol 10:236\u2013243. https:\/\/doi.org\/10.1215\/15228517-2008-006","journal-title":"Neuro Oncol"},{"key":"4505_CR74","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2174\/156652406775574523","volume":"6","author":"J Li","year":"2006","unstructured":"Li J, Lee A (2006) Stress induction of GRP78\/BiP and its role in Cancer. Curr Mol Med 6:45\u201354. https:\/\/doi.org\/10.2174\/156652406775574523","journal-title":"Curr Mol Med"},{"key":"4505_CR75","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11010-010-0556-9","volume":"345","author":"DG Garcia","year":"2010","unstructured":"Garcia DG, Amorim LMF, de Castro Faria MV et al (2010) The anticancer drug Perillyl alcohol is a Na\/K-ATPase inhibitor. Mol Cell Biochem 345:29\u201334. https:\/\/doi.org\/10.1007\/s11010-010-0556-9","journal-title":"Mol Cell Biochem"},{"key":"4505_CR76","first-page":"1917","volume":"59","author":"EA Ariazi","year":"1999","unstructured":"Ariazi EA, Satomi Y, Ellis MJ et al (1999) Activation of the transforming growth factor beta signaling pathway and induction of cytostasis and apoptosis in mammary carcinomas treated with the anticancer agent Perillyl alcohol. Cancer Res 59:1917\u20131928","journal-title":"Cancer Res"},{"key":"4505_CR77","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1124\/jpet.104.070516","volume":"311","author":"H Loutrari","year":"2004","unstructured":"Loutrari H, Hatziapostolou M, Skouridou V et al (2004) Perillyl alcohol is an angiogenesis inhibitor. J Pharmacol Exp Ther 311:568\u2013575. https:\/\/doi.org\/10.1124\/jpet.104.070516","journal-title":"J Pharmacol Exp Ther"},{"key":"4505_CR78","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/ptr.8081","volume":"38","author":"A Mathur","year":"2024","unstructured":"Mathur A, Meena A, Luqman S (2024) Monoterpenoids: an upcoming class of therapeutic agents for modulating cancer metastasis. Phytother Res 38:939\u2013969. https:\/\/doi.org\/10.1002\/ptr.8081","journal-title":"Phytother Res"},{"key":"4505_CR79","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1158\/1535-7163.MCT-12-0321","volume":"11","author":"H-Y Cho","year":"2012","unstructured":"Cho H-Y, Wang W, Jhaveri N et al (2012) Perillyl alcohol for the treatment of Temozolomide-Resistant gliomas. Mol Cancer Ther 11:2462\u20132472. https:\/\/doi.org\/10.1158\/1535-7163.MCT-12-0321","journal-title":"Mol Cancer Ther"},{"key":"4505_CR80","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.3390\/cancers16234003","volume":"16","author":"AC Batista Brochado","year":"2024","unstructured":"Batista Brochado AC, de Moraes JA, de Oliveira R B, et al (2024) Metabolic and regulatory pathways involved in the anticancer activity of Perillyl alcohol: A scoping review of in vitro studies. Cancers (Basel) 16:4003. https:\/\/doi.org\/10.3390\/cancers16234003","journal-title":"Cancers (Basel)"},{"key":"4505_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.intimp.2016.06.034","volume":"39","author":"J Ma","year":"2016","unstructured":"Ma J, Li J, Wang KS et al (2016) Perillyl alcohol efficiently scavenges activity of cellular ROS and inhibits the translational expression of hypoxia-inducible factor-1\u03b1 via mTOR\/4E-BP1 signaling pathways. Int Immunopharmacol 39:1\u20139. https:\/\/doi.org\/10.1016\/j.intimp.2016.06.034","journal-title":"Int Immunopharmacol"},{"key":"4505_CR82","doi-asserted-by":"crossref","unstructured":"S\u00f8gaard CK, Otterlei M (2024) Targeting proliferating cell nuclear antigen (PCNA) for cancer therapy. pp 209\u2013246","DOI":"10.1016\/bs.apha.2024.04.002"},{"key":"4505_CR83","doi-asserted-by":"publisher","unstructured":"Sch\u00f6nthal AH, Peereboom DM, Wagle N et al (2021) Phase I trial of intranasal NEO100, highly purified Perillyl alcohol, in adult patients with recurrent glioblastoma. https:\/\/doi.org\/10.1093\/noajnl\/vdab005. Neurooncol Adv 3:","DOI":"10.1093\/noajnl\/vdab005"},{"key":"4505_CR84","doi-asserted-by":"publisher","unstructured":"Minea RO, Thein TZ, Yang Z et al (2024) NEO212, Temozolomide conjugated to NEO100, exerts superior therapeutic activity over Temozolomide in preclinical chemoradiation models of glioblastoma. Neurooncol Adv 6. https:\/\/doi.org\/10.1093\/noajnl\/vdae095","DOI":"10.1093\/noajnl\/vdae095"},{"key":"4505_CR85","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1080\/15548627.2023.2242696","volume":"19","author":"M Ou","year":"2023","unstructured":"Ou M, Cho H-Y, Fu J et al (2023) Inhibition of autophagy and induction of glioblastoma cell death by NEO214, a Perillyl alcohol-rolipram conjugate. Autophagy 19:3169\u20133188. https:\/\/doi.org\/10.1080\/15548627.2023.2242696","journal-title":"Autophagy"},{"key":"4505_CR86","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1158\/1535-7163.MCT-18-0465","volume":"18","author":"H-Y Cho","year":"2019","unstructured":"Cho H-Y, Thein TZ, Wang W et al (2019) The Rolipram\u2013Perillyl alcohol conjugate (NEO214) is A mediator of cell death through the death receptor pathway. Mol Cancer Ther 18:517\u2013530. https:\/\/doi.org\/10.1158\/1535-7163.MCT-18-0465","journal-title":"Mol Cancer Ther"},{"key":"4505_CR87","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1535-6108(04)00115-1","volume":"5","author":"BJ Moeller","year":"2004","unstructured":"Moeller BJ, Cao Y, Li CY, Dewhirst MW (2004) Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors. Cancer Cell 5:429\u2013441. https:\/\/doi.org\/10.1016\/S1535-6108(04)00115-1","journal-title":"Cancer Cell"},{"key":"4505_CR88","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.radmp.2020.01.006","volume":"1","author":"R Huang","year":"2020","unstructured":"Huang R, Zhou P-K (2020) HIF-1 signaling: A key orchestrator of cancer radioresistance. Radiat Med Prot 1:7\u201314. https:\/\/doi.org\/10.1016\/j.radmp.2020.01.006","journal-title":"Radiat Med Prot"},{"key":"4505_CR89","first-page":"51","volume":"80","author":"JE Ziello","year":"2007","unstructured":"Ziello JE, Jovin IS, Huang Y (2007) Hypoxia-Inducible factor (HIF)-1 regulatory pathway and its potential for therapeutic intervention in malignancy and ischemia. Yale J Biol Med 80:51\u201360","journal-title":"Yale J Biol Med"},{"key":"4505_CR90","first-page":"3777","volume":"11","author":"Z Han","year":"2021","unstructured":"Han Z, Dong Y, Lu J et al (2021) Role of hypoxia in inhibiting dendritic cells by VEGF signaling in tumor microenvironments: mechanism and application. Am J Cancer Res 11:3777\u20133793","journal-title":"Am J Cancer Res"},{"key":"4505_CR91","doi-asserted-by":"publisher","first-page":"601","DOI":"10.5483\/BMBRep.2021.54.12.165","volume":"54","author":"HJ Cho","year":"2021","unstructured":"Cho HJ, Koo J (2021) Odorant G protein-coupled receptors as potential therapeutic targets for adult diffuse gliomas: a systematic analysis and review. BMB Rep 54:601\u2013607. https:\/\/doi.org\/10.5483\/BMBRep.2021.54.12.165","journal-title":"BMB Rep"},{"key":"4505_CR92","doi-asserted-by":"publisher","unstructured":"Wang Q, He Z, Chen Y (2019) Comprehensive analysis reveals a 4-Gene signature in predicting response to Temozolomide in Low-Grade glioma patients. Cancer Control 26. https:\/\/doi.org\/10.1177\/1073274819855118","DOI":"10.1177\/1073274819855118"},{"key":"4505_CR93","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1124\/pharmrev.120.000269","volume":"73","author":"DJ Ramms","year":"2021","unstructured":"Ramms DJ, Raimondi F, Arang N et al (2021) G\u03b1s\u2013Protein kinase A (PKA) pathway signalopathies: the emerging genetic landscape and therapeutic potential of human diseases driven by aberrant G\u03b1s-PKA signaling. Pharmacol Rev 73:1326\u20131368. https:\/\/doi.org\/10.1124\/pharmrev.120.000269","journal-title":"Pharmacol Rev"},{"key":"4505_CR94","doi-asserted-by":"publisher","first-page":"72","DOI":"10.5483\/BMBRep.2022.55.2.010","volume":"55","author":"C Chung","year":"2022","unstructured":"Chung C, Cho HJ, Lee C, Koo J (2022) Odorant receptors in cancer. BMB Rep 55:72\u201380. https:\/\/doi.org\/10.5483\/BMBRep.2022.55.2.010","journal-title":"BMB Rep"},{"key":"4505_CR95","doi-asserted-by":"publisher","first-page":"2","DOI":"10.5808\/GI.2018.16.1.2","volume":"16","author":"SJ Oh","year":"1970","unstructured":"Oh SJ (1970) System-Wide expression and function of olfactory receptors in mammals. Genomics Inf 16:2\u20139. https:\/\/doi.org\/10.5808\/GI.2018.16.1.2","journal-title":"Genomics Inf"},{"key":"4505_CR96","doi-asserted-by":"publisher","unstructured":"Vadevoo SMP, Gunassekaran GR, Lee C et al (2021) The macrophage odorant receptor Olfr78 mediates the lactate-induced M2 phenotype of tumor-associated macrophages. Proceedings of the National Academy of Sciences 118:. https:\/\/doi.org\/10.1073\/pnas.2102434118","DOI":"10.1073\/pnas.2102434118"},{"key":"4505_CR97","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3390\/life14050548","volume":"14","author":"MR Beito","year":"2024","unstructured":"Beito MR, Ashraf S, Odogwu D, Harmancey R (2024) Role of ectopic olfactory receptors in the regulation of the Cardiovascular\u2013Kidney\u2013Metabolic Axis. Life 14:548. https:\/\/doi.org\/10.3390\/life14050548","journal-title":"Life"},{"key":"4505_CR98","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1084\/jem.154.6.1899","volume":"154","author":"Y Takasaki","year":"1981","unstructured":"Takasaki Y, Deng JS, Tan EM (1981) A nuclear antigen associated with cell proliferation and blast transformation. J Exp Med 154:1899\u20131909. https:\/\/doi.org\/10.1084\/jem.154.6.1899","journal-title":"J Exp Med"},{"key":"4505_CR99","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3390\/biom10040570","volume":"10","author":"A Gonz\u00e1lez-Maga\u00f1a","year":"2020","unstructured":"Gonz\u00e1lez-Maga\u00f1a A, Blanco FJ (2020) Human PCNA structure, function and interactions. Biomolecules 10:570. https:\/\/doi.org\/10.3390\/biom10040570","journal-title":"Biomolecules"},{"key":"4505_CR100","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.3390\/v16081264","volume":"16","author":"A Kwan","year":"2024","unstructured":"Kwan A, Mcdermott-Brown I, Muthana M (2024) Proliferating cell nuclear antigen in the era of oncolytic virotherapy. Viruses 16:1264. https:\/\/doi.org\/10.3390\/v16081264","journal-title":"Viruses"},{"key":"4505_CR101","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3390\/cancers14020289","volume":"14","author":"G Gravina","year":"2022","unstructured":"Gravina G, Colapietro A, Mancini A et al (2022) ATX-101, a peptide targeting PCNA, has antitumor efficacy alone or in combination with radiotherapy in murine models of human glioblastoma. Cancers (Basel) 14:289. https:\/\/doi.org\/10.3390\/cancers14020289","journal-title":"Cancers (Basel)"},{"key":"4505_CR102","doi-asserted-by":"publisher","unstructured":"Low JT, Brown MC, Reitman ZJ et al (2024) Understanding and therapeutically exploiting cGAS\/STING signaling in glioblastoma. J Clin Invest 134. https:\/\/doi.org\/10.1172\/JCI163452","DOI":"10.1172\/JCI163452"},{"key":"4505_CR103","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/s43018-022-00468-w","volume":"3","author":"N Samson","year":"2022","unstructured":"Samson N, Ablasser A (2022) The cGAS\u2013STING pathway and cancer. Nat Cancer 3:1452\u20131463. https:\/\/doi.org\/10.1038\/s43018-022-00468-w","journal-title":"Nat Cancer"},{"key":"4505_CR104","doi-asserted-by":"publisher","unstructured":"Altundag A, Harbi E (2025) Potential role of terpenes in recovery from olfactory dysfunction with olfactory training: a review. Mol Biol Rep 52(1):700. https:\/\/doi.org\/10.1007\/s11033-025-10795-7","DOI":"10.1007\/s11033-025-10795-7"},{"key":"4505_CR105","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1158\/1940-6207.CAPR-09-0183","volume":"3","author":"SP Stratton","year":"2010","unstructured":"Stratton SP, Alberts DS, Einspahr JG et al (2010) A phase 2a study of topical Perillyl alcohol cream for chemoprevention of skin Cancer. Cancer Prev Res 3:160\u2013169. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-09-0183","journal-title":"Cancer Prev Res"},{"key":"4505_CR106","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.taap.2005.10.002","volume":"213","author":"NLS Chan","year":"2006","unstructured":"Chan NLS, Wang H, Wang Y et al (2006) Polycyclic aromatic hydrocarbon-induced CYP1B1 activity is suppressed by Perillyl alcohol in MCF-7 cells. Toxicol Appl Pharmacol 213:98\u2013104. https:\/\/doi.org\/10.1016\/j.taap.2005.10.002","journal-title":"Toxicol Appl Pharmacol"},{"key":"4505_CR107","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.3390\/pharmaceutics13122167","volume":"13","author":"TC Chen","year":"2021","unstructured":"Chen TC, da Fonseca CO, Levin D, Sch\u00f6nthal AH (2021) The monoterpenoid Perillyl alcohol: anticancer agent and medium to overcome biological barriers. Pharmaceutics 13:2167. https:\/\/doi.org\/10.3390\/pharmaceutics13122167","journal-title":"Pharmaceutics"},{"key":"4505_CR108","doi-asserted-by":"publisher","unstructured":"Harbi E, Aschner M (2024) Role of BRCA1 in glioblastoma etiology. Cell Oncol 47:2091\u20132098. https:\/\/doi.org\/10.1007\/s13402-024-01024-7","DOI":"10.1007\/s13402-024-01024-7"},{"key":"4505_CR109","doi-asserted-by":"publisher","unstructured":"Sch\u00f6nthal AH, Swenson S, Bonney PA et al (2022) Detection of Perillyl alcohol and its metabolite Perillic acid in postsurgical glioblastoma tissue after intranasal administration of NEO100: illustrative case. J Neurosurgery: Case Lessons 4. https:\/\/doi.org\/10.3171\/CASE22215","DOI":"10.3171\/CASE22215"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-025-04505-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-025-04505-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-025-04505-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T08:58:09Z","timestamp":1756371489000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-025-04505-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":109,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["4505"],"URL":"https:\/\/doi.org\/10.1007\/s11064-025-04505-9","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,29]]},"assertion":[{"value":"30 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is a review and does not involve any human or animal participants, nor does it require ethical approval. Therefore, statements regarding ethical approval, consent to participate, or consent to publish are not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"254"}}